feed,title,long_url,short_url
MX,First phase 3 trial of a chikungunya vaccine candidate finds it is generally safe and provokes an immune response,https://medicalxpress.com/news/2023-06-phase-trial-chikungunya-vaccine-candidate.html,https://da.gd/8RPDT3
